Skip to content

Analysts set Cerebras stock price target for 12 months

Analysts set Cerebras stock price target for 12 months
Steve Muchoki

Amid the rising demand for Artificial Intelligence (AI) products, several analysts have issued a 12-month bullish signal for Cerebras Systems, Inc. (NASDAQ: CBRS) stock.

On Wednesday, June 24, 2026, Barclays PLC (London: BARC) analyst Thomas O’Malley maintained a ‘Buy’ rating for Cerebras stock. Additionally, O’Malley set a 12-month Cerebras stock price target of $280.  

On Tuesday, Wall Street analyst Joshua Buchalter from TD Cowen reiterated a ‘Buy’ rating for Cerebras stock. Buchalter set a 12-month price target of about $275 for CBRS stock.

On the same day, Vijay Rakesh from Mizuho Securities reiterated a ‘Buy’ rating for Cerebras Systems stock. Rakesh set a 12-month price target of $300.

Earlier on Monday, Matt Bryson from Wedbush maintained a ‘Buy’ rating for CBRS stock. Notably, Bryson set a 12-month price target of about $270.

As such, CBRS stock has received a strong buy signal from 10 analysts, according to data from TipRanks. Based on these strong buy ratings, the average 12-month target for Cerebras Systems stock price is about $294 at the time of publication.

CBRS stock price targets. Source: TipRanks

Why are analysts bullish on Cerebras stock price in the near future?

Analysts are strongly bullish on Cerebras Systems stock due to the explosive demand for its products, which compete with Nvidia Corp. (NASDAQ: NVDA). Furthermore, the company reported GAAP revenue of $193.4 million, up 94% year over year (YoY).

Additionally, Cerebras Systems reported core revenue of $191.3 million, representing 92% year-over-year growth, driven by approximately 60% growth in core hardware revenue and a 167% surge in cloud and services revenue.

Meanwhile, analysts could be bullish on CBRS stock as it may have found strong support following its post-IPO (Initial Public Offering) sell-off.

CBRS stock 1-day chart. Source: TradingView

After closing Tuesday trading at about $226.72, CBRS stock hovered around $194.85 during the pre-market session. Having printed its lowest price, analysts believe Cerebras Systems stock could be approaching a potential reversal bolstered by robust fundamentals.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users worldwide
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD
Finbold Career

Join Finbold's newsroom, become a Sales Executive today!

Apply now to join Finbold as a crypto/finance news writer!

Latest posts

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.